Though anaphylaxis is rare, you are more likely to be murdered this Thanksgiving than die from a food allergy, companies and schools are increasingly buying epinephrine auto-injectors (EpiPens), which has led to shortages (government approval policies make it difficult for competitors to enter the market) and thus high costs. Though rare, the consequences of anaphylaxis are high, much more severe than using it when it might not be necessary.
If you are one of the millions of people in the U.S. who now carries an epinephrine auto injector (EAI) you probably wondered if it will still work if it freezes this winter. It will, according to new research being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting.